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Abstract
Oral surgery in patients with bleeding disorders is associated with a high risk of
bleeding during and after surgery. This article is aimed to present the case of an
eight-year-old girl suffering from severe Fanconi anemia with pancytopenia who
underwent a dental extraction. The hemostatic effect of local administration of
tranexamic acid in combination with a primary suture seems to be extremely helpful in order to reduce the necessity of blood products and the risk of postoperative
bleeding.
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INTRODUCTION
Fanconi anemia (FA) is a rare autosomal recessive disorder characterized by congenital
malformations, progressive bone marrow hypoplasia, and a high risk of malignancies. The
existing literature describes occurrence frequency of FA with approximately 1:360,000
[1] with a female-to-male ratio of 1:2 [2]. Fifteen genetic subtypes can be distinguished:
FA-A, -B, -C, -D1, -D2, -E, -F, -G, -I, -J, -L, M, -N, -O, and –P. The majority of FA patients (∼85%) belong to subtypes A (∼60%),
C (∼10–15%), or G (∼10%), while a minority
(∼15%) is distributed over the remaining 12
subtypes [3]. Cells of FA patients are characteristically sensitive to chromosome breakage
by DNA cross-linking agents [4].
www.jdt.tums.ac.ir September 2014; Vol. 11, No. 5

The diagnosis is usually made between the age
of 5 and 10 years [5]. Whereas, one third of
the affected patients do not have any obvious
abnormalities, in the majority of cases, physical signs, such as abnormal skin pigmentation,
short stature, thumb and radial anomalies,
structural renal defects, microcephaly, and delayed development are recognizable at birth
and during early childhood.
The most frequent oral manifestations are gingivitis, periodontitis, rotated teeth, and dental
agenesis [6]. The high prevalence of periodontal diseases and gingivitis may be related to
frequent immune system deficiencies, anemia
and leukopenia. However, patients affected by
FA often display deficits in their oral hygiene
as well [7].
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Fig 1. Physical examination: skin hypopigmented areas and hypertrichosis. Photograph of the entire
body of the patient shows scoliosis.

Furthermore, they are predisposed to the development of squamous cell carcinoma (SCC),
especially in the oral cavity [8].
Many FA patients experience bone marrow
failure, which is generally characterized by an
increasing pancytopenia, often initially with
thrombocytopenia or leukopenia. In general,
bone marrow transplantation is currently the
most effective treatment to cure severe aplastic anemia or acute myeloid leukemia and the
myelodysplastic syndrome [9]. All patients
designated for transplantation should be examined for presence of any active infection.
Dentists should carefully exam the oral situation within the pre-transplant evaluation. Decayed teeth have to be restored and destroyed
teeth must be removed before transplantation.
It is difficult to find the optimal management
for patients with FA when they need oral surgery, because of their susceptibility to infections and pancytopenia. The following report
discusses the management of such a patient,
who underwent a dental extraction.
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CASE REPORT
The patient was an eight-year-old Syrian girl
(body weight, 28 kilograms; body height, 127
centimeters).
Diagnosed with FA, she was referred to our
clinic to evaluate her dental health before
planning bone marrow transplantation. Her
parents and her siblings (9- and 11-year-old
brothers) were not affected by the disease.
The physical examination showed a young girl
with clinical signs of FA including skin hypopigmented areas, hypertrichosis, scoliosis, abnormal ribs and multiple hematomas in the
region of the thighs (Fig 1).
The hexadactyly of her left hand was surgically corrected three months after birth. The oral
examination revealed several decayed teeth
(Fig 2 and 3).
In the lower jaw 74, 75, 84 and 85 were totally
destroyed by caries and therefore, indicated
for extraction.
The results of the laboratory tests are mentioned in Table 1.
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Fig 2. Panoramic radiograph before dental treatment

The most noticeable aspect was the severe
thrombocytopenia (5,000/µL). A mild hypersensitivity reaction after platelet transfusion in
the past was recorded in her file.
Preparation of dental treatment was carried out
in close cooperation with the Hemotology Oncology Unit of our hospital. Due to the FA related severe thrombocytopenia, a platelet concentrate was necessary to raise the platelet
count above 50,000/µL. After the intravenous
(IV) premedication with 50 mg glucocorticoid
(prednisolone) and 3 mg antihistaminic agent
(dimetinden), which was required to avoid
another transfusion reaction, a single unit of
leuko-depleted and irradiated apheresis platelets, was given intravenously. A platelet count
of 75,000/µL was achieved. The treatment was
performed under general anesthesia to avoid
age-related noncompliance. Prophylactic antibiotic treatment using 1.5 g ampicillin/sulbactam IV (ampicillin HEXAL® comp,
Hexal, Holzkirchen, Germany) was given to
reduce the risk of postoperative infection.

Fig 3. Preoperative photograph. Teeth number
74 and 75 are completely destroyed.

A buccal infiltration using a total of 2.0 mL of
4.0% articain with adrenaline 1:200,000 (Ultracain D-S, Sanofi-Aventis, Paris, France)
was conducted for local anaesthesia.
We started with the restorative treatment of
teeth 54, 65, 16, 26, 36 and 46.
Following that, 74, 75, 84 and 85 were extracted. The sockets were immediately covered with tranexamic acid (TA) (Cyklokapron,
Meda Pharma, Bad Homburg, Germany) and
closed with a 4x0 resorbable suture (Vicryl,
Ethicon Johnson & Johnson, New Brunswick,
USA) (Fig 4 and 5).
Gauzes saturated with TA were placed onto
the teeth sockets for five minutes. Following
this protocol, an excellent hemostasis was
achieved. The patient was kept in hospital for
observation. Gauzes saturated with TA were
applied for local hemostasis during the following three days to avoid any late postoperative
bleeding caused by early fibrinolysis and
hyperfibrinolysis, Postoperative pain was controlled by paracetamol.

Table 1. Laboratory Findings
Reference range

Findings

White blood cells

4,3-11,4x103/µL

2,0x103/µL

Red blood cells

3,9-5,0x106/µL

3,5*106/µL

Hemoglobin

6,6-8,2 mmol/L

6,3 mmol/L

Hematocrit

0,32-0,40

0,28

150.000-400.000/µL

5.000/µL

0,8-1,2
30-50 s

0,9
35 s

Platelets
INR
Partial thromboplastin time
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Fig 5. Perioperative photograph. The teeth sockets
74 and 75 after elevation and flooded with TA.

The diet (consisted of cool liquids followed by
semi-solid food for 3 days after operation. No
postoperative bleeding appeared during the
observational period.
The platelet count was observed after surgery.
No further blood products were necessary despite a decrease to 6,000/µL on the sixth day
after operation.
DISCUSSION
The predominant symptom of FA is the progressive bone marrow failure usually during
early childhood with increasing pancytopenia,
often initial with thrombocytopenia or leukopenia. Because of the important role of platelets in hemostasis in forming the initial plug in
vessel injuries, severe thrombocytopenia
presents a high risk for a postoperative hemorrhage after dental extraction in these patients.
The threshold platelet count for thrombocytopenic patients who have to undergo surgical
procedures remains unclarified in the current
literature. It is however, common practice to
increase the platelet count to at least
50,000/µL. For procedures in critical regions,
such as the brain or eyes and for major surgery, the platelet count should be raised to at
least 100,000/µL [10,11].
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Fig 4. Immediate postoperative photograph. The
sockets are closed with resorbable suture

Obtaining a post transfusion platelet count is
required before starting surgery. Depending on
the expected level of hemorrhage, additional
platelet concentrates can be transfused intraoperatively and postoperatively [11]. In addition, the use of local hemostatic measures is
necessary to reduce the need of blood products
and the risk of postoperative bleeding. We
used TA, a synthetic derivative of the amino
acid lysine that causes an antifibrinolytic activity in humans. It reversibly attaches to the
lysine-binding site of plasminogen and blocks
the binding to fibrin as well as its activation
and transformation to plasmin. Thereby, the
fibrinolysis and blood clot degradation is retarded [12]. In some countries, TA is not
available. Epsilon aminocaproic acid (EA) has
a similar effect. However, EA exhibits a
slightly shorter plasma half-life and shows less
antifibrinolytic activity than TA [13]. Various
reports referred to the successful local use of
TA in order to reduce oral bleeding and the
need of blood products after oral surgery in
patients with bleeding disorders [14,15]. Other
local measures such as collagen fleece [16],
oxidized cellulose [17], gelatin sponge [11],
fibrin glue [18] and cyanoacrylate [19] are also reported to be helpful for local hemostasis.
Furthermore, these measures may be comwww.jdt.tums.ac.ir September 2014; Vol. 11, No. 5
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bined with antifibrinolytic drugs to potentiate
the hemostatic effect. In addition, systemic EA
or TA may be used if local hemostasis and
platelet transfusion appear inadequate. A loading dose of 10 g intravenous followed by 1 g/h
is recommended to achieve an effective plasma concentration [11]. In order to prevent
secondary bleeding, resorbable suture material
was used to avoid suture removal. Nonsteroidal, anti-inflammatory drugs and aspirin,
which inhibit the platelet function, must be
avoided for pain control. Paracetamol is a safe
alternative to prevent postoperative pain.
There are successful treatment protocols in the
current literature for patients affected by
thrombocytopenia. Engel et al. [16] describe
the successful management of a female FA
patient undergoing bone grafting and dental
implant placement. The platelet count in this
case was 25,000/µL. The patient received 1 U
of single donor platelets preoperatively. EA
was given via continuous infusion during the
procedure at the rate of 500 mg/h. Additional
pooled platelets and packed red blood cells
were given intraoperatively. After taking the
graft from the anterior iliac crest they used
collagen fleece for local hemostasis. Two units
of fresh frozen plasma were given postoperatively and the EA infusion was continued at
500 mg/h for 8 hours. A total blood loss of
1,000 mL was registered. Because of a platelet
count of 64,000/µL, no blood products were
necessary for the abutment placement in the
mandible after 4 months and the maxilla after
8 months. The patient received only 500 mg
EA orally, every 6 hours starting the day before the procedure and continuing 2 days postoperatively. All implants were noted to have
solid osseointegration without difficulty and
with adequate hemostasis.
Henderson et al. [11] reported three treatment
protocols for patients with thrombocytopenia
undergoing dental extraction. Platelet transfusions were combined in one case with gelatin
sponge for local hemostasis. In all cases, the
surgical sites were closed primarily.
www.jdt.tums.ac.ir September 2014; Vol. 11, No. 5

One patient presented postoperative hemorrhage, which was managed systemically with
multiple transfusions of packed red blood cells
and platelets and topically with thrombinsoaked gauze over the surgical sites as an adjunctive hemostatic measure. This is an indication that postoperative bleeding after oral surgery in patients exhibiting thrombocytopenia
is difficult to predict, even though defined
treatment protocols are used. Postoperative
monitoring of these patients is required to prevent excessive hemorrhage.
While the risk for hematologic diseases is
greater during early childhood, solid tumors,
particularly SCC, are most frequently observed in adults [4,20].
SCC in FA patients develops earlier than in
the general population and shows a more aggressive behavior [4]. An average age of 27
years in FA patients (21) and an average time
between the age of FA diagnosis and cancer
development of 10.5 years [22] have been reported in the literature. The commonest localizations of SCC in FA patients in descending
order are: the tongue, anogenital region, pharynx, larynx, oral mucosa, mandible and skin
[23].
There are indications that the incidence of malignancy development is greater after FA patients have endured bone marrow transplantation, maybe by adding risk factors, such as
pre-transplantation conditioning with chemotherapy and radiotherapy, immunosuppressive
agents given for prophylaxis of graft versus
host disease (GVHD) and GVHD itself [23].
Concerning the high risk of development malignancies, a biannual screening of the oral
cavity and oropharynx starting between the
ages of 15 and 20 is recommended. FA patients with a history of leukoplakia or recurrent oral lesions should be followed every six
or eight weeks [4]. If malignancies are diagnosed, operative procedures in FA patients
with head and neck cancer are similar to the
general population with similar pathologies
[24,25].
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The associated bone marrow failure in FA patients requires preoperative consultation in a
Hematology Oncology Treatment Centre. The
need of blood and platelet transfusion before
surgery must be considered [24]. Besides the
risk of development of wound infections and
hematoma, FA patients can have serious problems in adjuvant therapy [4,26]. Because of
the increased susceptibility to mutagenic stimuli [27], standard doses of radiotherapy and
chemotherapy are generally reduced [24].
CONCLUSION
The topical administration of TA in combination with primary suture and perioperative
transfusion of platelets seems to be effective in
the prevention of postoperative hemorrhage in
patients with severe thrombocytopenia undergoing dental extraction. It is essential to follow defined surgical protocols in the management of patients with bleeding disorders. A
specialized dental service should perform
these procedures in close cooperation with a
hematology oncology treatment centre. The
high risk of developing an oral squamous cell
carcinoma for patients affected by FA, requires a frequent oral examination by dental
practitioners.
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